Sean Matthews Selected Research

Vaccines

2/2024	The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age.
1/2022	An Easy-to-Implement Clinical-Trial Frailty Index Based on Accumulation of Deficits: Validation in Zoster Vaccine Clinical Trials.
12/2021	Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany.
1/2021	Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals.
1/2020	Burden-of-illness vaccine efficacy.
12/2019	Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older.
1/2019	Evaluation of two frailty indices, with practical application in a vaccine clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sean Matthews Research Topics

Disease

8	Herpes Zoster 01/2023 - 12/2019
6	Pain (Aches) 01/2023 - 10/2018
3	Frailty 01/2022 - 01/2019
2	Exanthema (Rash) 12/2022 - 01/2021
1	Infections 02/2024
1	Breakthrough Infections 02/2024
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2023
1	Whooping Cough (Pertussis) 01/2020
1	Human Influenza (Influenza) 01/2020
1	Vaccine-Preventable Diseases 01/2020

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 02/2024 - 01/2019
5	Herpes Zoster VaccineIBA 01/2022 - 12/2019
1	Proteins (Proteins, Gene)FDA Link 02/2024

Therapy/Procedure

6	Activities of Daily Living (ADL) 01/2023 - 10/2018
2	Hematopoietic Stem Cell Transplantation 01/2023 - 12/2022
1	Long-Term Care 04/2023
1	Therapeutics 12/2022